🇺🇸 Fluoropyrimidine in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 27

Most-reported reactions

1. Drug Resistance — 9 reports (33.33%)
2. Toxicity To Various Agents — 6 reports (22.22%)
3. Arthralgia — 2 reports (7.41%)
4. Disease Progression — 2 reports (7.41%)
5. Hypomagnesaemia — 2 reports (7.41%)
6. Leukopenia — 2 reports (7.41%)
7. Abdominal Pain — 1 report (3.7%)
8. Alopecia — 1 report (3.7%)
9. Anaemia — 1 report (3.7%)
10. Atrial Flutter — 1 report (3.7%)

Source database →

Frequently asked questions

Is Fluoropyrimidine approved in United States?

Fluoropyrimidine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fluoropyrimidine in United States?

Centre Hospitalier Universitaire Dijon is the originator. The local marketing authorisation holder may differ — check the official source linked above.